New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Pfizer Inc.
PFE
Shape
US Flag

NYSE

146B

Drug Manufacturers - General

Next Earning date - 07 May 2025

146B

Drug Manufacturers - General

Next Earning date - 07 May 2025

26.20USD

Shape-0.32 ( -1.21%)
sun-fogPre-market 26.73$arrow-right-up0.54 (2.04%)
Market Closed (as of Feb 03, 21:00 EDT)
favorite-chart

Relative Strenght

27
favorite-chart

Volume Buzz

-9%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

17%

Quote Panel

Shape
Updated February 7, 2025
1W -1.41 % 1M -2.23 % 3M -1.75 % 1Y -0.42 %

Key Metrics

Shape
  • Market Cap

    146.38B


  • Shares Outstanding

    5.67B


  • Share in Float

    5.66B


  • Dividende

    1.69


  • Earning Date

    07 May 2025


  • Price Target

    25.83


  • Average Volume

    43.67M


  • Beta

    0.615


  • Range

    24.48-31.54


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.pfizer.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

PFE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$63B

Shape256%

2025-Revenue

$2.91

Shape268%

2025-EPS

$21B

Shape183%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

32.00(23.89%)

Number of analyst

1

Last analyst upgrade/downgrade

Bernstein

initialise

Previous: Not converted

2024-10-17

Now: Market Perform

Guggenheim

initialise

Previous: Not converted

2024-07-30

Now: Buy

RBC Capital

downgrade

Previous: Not converted

2024-05-28

Now: Cautious

Cowen & Co.

downgrade

Previous: Outperform

2024-01-29

Now: Market Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+6%

1.14
vs 1.08

Q2.23

arrow
arrow

-26%

1.23
vs 1.67

Q3.23

arrow
arrow

-67%

0.67
vs 2.04

Q4.23

arrow
arrow

N/A

-0.17
vs 1.14

Q4.23

arrow
arrow

-91%

0.1
vs 1.14

Q1.24

arrow
arrow

N/A

0.82
vs NA

Q2.24

arrow
arrow

-51%

0.6
vs 1.23

Q3.24

arrow
arrow

+58%

1.06
vs 0.67

Q4.24

arrow
arrow

+372%

0.47
vs 0.1

Q1.25

arrow
arrow

-15%

0.7
vs 0.82

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+2%

24.3B  vs 23.8B

Q2.23

arrow
arrow

-29%

18.3B  vs 25.7B

Q3.23

arrow
arrow

-54%

12.7B  vs 27.7B

Q4.23

arrow
arrow

-46%

13.2B  vs 24.3B

Q4.23

arrow
arrow

-41%

14.2B  vs 24.3B

Q1.24

arrow
arrow

NA

14.9B  vs NA

Q2.24

arrow
arrow

-27%

13.3B  vs 18.3B

Q3.24

arrow
arrow

+39%

17.7B  vs 12.7B

Q4.24

arrow
arrow

+22%

17.4B  vs 14.2B

Q1.25

arrow
arrow

-3%

14.4B  vs 14.9B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+5%

0.05
vs 0.09

Q2.23

arrow
arrow

+5%

0.05
vs 0.05

Q3.23

arrow
arrow

+2%

0.02
vs 0.05

Q4.23

arrow
arrow

-2%

-0.02
vs 0.02

Q4.23

arrow
arrow

-4%

-0.04
vs -0.02

Q1.24

arrow
arrow

+3%

0.03
vs -0.04

Q2.24

arrow
arrow

+0%

0
vs 0.03

Q3.24

arrow
arrow

+5%

0.05
vs 0

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

3340

3.3K
vs 3.2K

6%

Q1.23

arrow
arrow

3185

3.2K
vs 3.3K

-5%

Q2.23

arrow
arrow

3117

3.1K
vs 3.2K

-2%

Q3.23

arrow
arrow

3014

3K
vs 3.1K

-3%

Q4.23

arrow
arrow

3034

3K
vs 3K

1%

Q1.24

arrow
arrow

2963

3K
vs 3K

-2%

Q2.24

arrow
arrow

2979

3K
vs 3K

1%

Q3.24

arrow
arrow

2987

3K
vs 3K

0%

Earnings Growth

Latest News

PFE

forbes.com

11 hours ago